⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
PRLB News
PROTO LABS, INC.
Form 8-K
sec.gov
PRLB
Protolabs Reports Financial Results for the First Quarter of 2026
businesswire.com
PRLB
JASMINE Trial Demonstrates Prolacta's Human Milk-Based Fortifiers Deliver Superior Growth in Premature Infants While Maintaining Japan's Renowned Low NEC Rate
prnewswire.com
PRLB
Protolabs Sets Conference Call to Discuss First Quarter 2026 Financial Results
businesswire.com
PRLB
Protolabs Joins Space Foundation to Help Propel Aerospace Innovation into a New Space Age
businesswire.com
PRLB
Protolabs to Attend 2026 Cantor Global Technology & Industrial Growth Conference on March 10, 2026
businesswire.com
PRLB
Une première mondiale en soins néonatals : le Japon approuve les fortifiants 100 % à base de lait humain de Prolacta Bioscience en tant que médicament sur ordonnance pour les nourissons vulnérables USA - Français USA - English USA - English USA - español
prnewswire.com
PRLB
Eine Weltneuheit in der Neugeborenenpflege: Japan genehmigt die zu 100 % aus Muttermilch hergestellten Nahrungsergänzungsmittel von Prolacta Bioscience als verschreibungspflichtiges Medikament für gefährdete Säuglinge. USA - Deutsch USA - español USA -
prnewswire.com
PRLB
Japón aprueba los fortificantes de Prolacta Bioscience, elaborados 100% con leche materna USA - español USA - English USA - English
prnewswire.com
PRLB
Protolabs Introduces ProDesk, an AI-Enabled Manufacturing Platform to Accelerate Projects from Prototyping to Production
businesswire.com
PRLB